Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.815,61
0,01%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MorphoSys AG (MOR) MorphoSys AG (MOR) Notizie

MorphoSys AG

MOR
17,87
-0,31 (-1,71%)
25 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/6/202408:47BWMorphoSys and Novartis Sign Delisting Agreement and Intend..
10/6/202417:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202422:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/6/202416:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202422:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
04/6/202416:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202416:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202416:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202416:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202416:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202420:19EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
23/5/202416:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202415:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202416:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/5/202416:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202422:43EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
16/5/202416:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202416:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202416:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/4/202422:01BWMorphoSys AG Reports First Quarter 2024 Financial Results
11/4/202414:39BWMorphoSys’ Management Board and Supervisory Board Recommend..
13/3/202421:02BWMorphoSys AG Reports Fourth Quarter and Full Year 2023..
06/2/202412:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
11/12/202301:31BWMorphoSys’ Pelabresib Improves All Four Hallmarks of..
20/11/202323:19DJNMorphoSys Trial for Blood-Cancer Treatment Reaches Primary..
20/11/202322:30BWMorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis..
15/11/202322:01BWMorphoSys AG Reports First Nine Months and Third Quarter..
09/8/202322:01BWMorphoSys AG Reports Second Quarter and First Half 2023..
Apertura: 18,06 Min: 17,80 Max: 18,20
Chiusura: 18,18

La tua Cronologia

NASDAQ
MOR
MorphoSys
TSX
CEMI
CIBC Emerging Markets Eq...
ASX
BXBSSL
LSE
BV74
Tow B24-2 A 66s
TSXV
VRD
Viridis Energy Inc.
BTHB
ADAKRW
Cardano
LSE
TYMN
Tyman
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network